ArticlebioRxiv : the preprint server for biology2024
Structural characterization of antibody-responses from Zolgensma treatment provides the blueprint for the engineering of an AAV capsid suitable for redosing.
Mario Mietzsch et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.